1. Medtech Insight

Upcoming Medtech Guidance: 35 New Or Revised Documents Due In 2025

 
• By Amanda Maxwell

The latest list includes a new EU document in the wings that addresses the designation of medtech notified bodies under the AI Act.

The FDA has set out its 2025 list of planned guidance (Shutterstock)

The European Commission’s Medical Device Coordination Group has started work on a document clarifying the designation process of notified bodies according to the AI Act (Regulation (EU) 2024/1689).

The text, which is being worked on by the MDCG’s Notified Bodies Oversight subgroup, is due to be endorsed by...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Medtech Insight

More from Policy & Regulation

MHRA’s Tallon Hails PMS Regulation As Start Of UK Device Framework Transformation

 
• By Ashley Yeo

16 June marked the first major new regulatory instrument in the UK’s post-Brexit transition to a standalone device regulatory system for Great Britain.

Increasing Safety Concerns Spur Scrutiny of Device Plastics Use

 
• By Elizabeth Orr

With new regulations limiting the use of plastics popping up worldwide, the medtech industry sees arguments on both sides. Some argue hasty bans of PFAS ("forever chemicals") would harm patients, while others say phthalates should be phased out to protect the public.

With LDT Rule DOA, Could FDA Shift Focus To RUOs?

 
• By Brian Bossetta

Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?